Anthracycline Resistance
Authors:
- T. SkovsgaardTST. Skovsgaard
- N. I. NissenNNN. I. Nissen
- 1 January 1989
- journal article
- review article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 28 (6) , 877-881
Abstract
The major limitation of the usefulness of anthracyclines is the development of drug resistance. Most of the data related to anthracycline resistance has been obtained in experimental animal tumors or in cultured human cell lines. An important characteristic obtained in these models is the common finding of cross-resistance to a series of drugs structurally unrelated to the anthracyclines and with a mechanism of action which apparently differ from that of the anthracyclines. This phenomenon is defined as pleiotropic drug resistance or multidrug resistance (MDR). The cross-resistance demonstrated includes the vinca alkaloids, actinomycin D, colchicin and the epipodophyllotoxins. The best documented mechanism of resistance and mechanism of cross-resistance is decreased cellular drug accumulation. Several findings indicate that the underlying factor of the altered net uptake is an active drug extrusion in the resistant cells. Another important characteristic is the demonstration of a cell surface protein with a molecular weight of about 170,000 (GP 170). Genetic and biochemical evidence indicate that the MDR phenotype in both animal and human cells result from overexpression of the MDR-1 gene which encodes GP 170. Some findings suggest that GP 170 is a transport protein for cytotoxic hydrophobic drugs like the anthracyclines. Other findings suggest that this gene is also associated with intrinsic (natural) anthracycline resistance.Keywords
This publication has 36 references indexed in Scilit:
- Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling.Proceedings of the National Academy of Sciences, 1986
- Isolation and genetic characterization of human KB cell lines resistant to multiple drugsSomatic Cell and Molecular Genetics, 1985
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983
- Cross resistance and cellular uptake of 4′-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicinCancer Chemotherapy and Pharmacology, 1981
- Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemiaBiochemical Pharmacology, 1981
- Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells.Proceedings of the National Academy of Sciences, 1981
- Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivoBiochemical Pharmacology, 1980
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- Reduced permeability in CHO cells as a mechanism of resistance to colchicineJournal of Cellular Physiology, 1974
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973